Home
Conditions
Neonatal Abstinence Syndrome

Clinical trial condition

Neonatal Abstinence Syndrome

Explore clinical trials studying Neonatal Abstinence Syndrome. Study availability and eligibility vary by location and protocol.

51 public trials 3 recruiting studies

Refine in advanced search Browse all conditions

Neonatal Abstinence Syndrome trial results

Completed

Weighted Blankets With Infants With NAS

NCT03113656

Conditions: Chemically-Induced Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Infant, Newborn, Diseases, +3 more
Locations: Good Samaritan Hospital Cincinnati, Ohio, United States

View Trial Details

Completed

Acupuncture in Neonatal Abstinence Syndrome (NAS) Babies

NCT02062151

Conditions: Chemically-Induced Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Infant, Newborn, Diseases, +3 more
Locations: Tampa General Hospital Tampa, Florida, United States

View Trial Details

Completed

Efficacy of Auricular Acupuncture on Neonatal Abstinence Syndrome

NCT02872077

Conditions: Chemically-Induced Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Infant, Newborn, Diseases, +3 more
Locations: USF Health Tampa, Florida, United States

View Trial Details

Completed

The Effect of Aromatherapy on Neonatal Abstinence Syndrome and Salivary Cortisol Levels

NCT03097484

Conditions: Aromatherapy, Chemically-Induced Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +4 more
Locations: University of Kentucky Lexington, Kentucky, United States

View Trial Details

Completed

Donor Human Milk in Neonatal Abstinence Syndrome

NCT02182973

Conditions: Chemically-Induced Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Infant, Newborn, Diseases, +3 more
Locations: University of Louisville Louisville, Kentucky, United States

View Trial Details

Completed

Comparison of Buprenorphine to Morphine in Treatment of Neonatal Abstinence Syndrome (NAS)

NCT01708707

Conditions: Chemically-Induced Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Infant, Newborn, Diseases, +4 more
Locations: Banner - University Medical Center Phoenix Phoenix, Arizona, United States

View Trial Details

Completed

Buprenorphine Dose Adjustments and Gestational Age

NCT03028883

Conditions: Chemically-Induced Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Infant, Newborn, Diseases, +3 more
Locations: Not specified

View Trial Details

Completed

Interest of Concentrations in Meconium of Buprenorphine and Methadone as a Prognostic Factor of NAS Outcome

NCT03334981

Conditions: Chemically-Induced Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Infant, Newborn, Diseases, +3 more
Locations: Caen University Hospital Caen, France

View Trial Details

Completed

Comparison Between Methadone and Morphine for Neonatal Opiate Withdrawal

NCT01804075

Conditions: Chemically-Induced Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Infant, Newborn, Diseases, +3 more
Locations: Not specified

View Trial Details

Completed

Fetal and Infant Effects of Maternal Buprenorphine Treatment

NCT01561079

Conditions: Chemically-Induced Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Infant, Newborn, Diseases, +3 more
Locations: Center for Addiction and Pregnancy Baltimore, Maryland, United States

Johns Hopkins Bayview Medical Center Baltimore, Maryland, United States

View Trial Details

Neonatal Abstinence Syndrome

Neonatal Abstinence Syndrome trial results

Related conditions